This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
ECCO2017 is a unique, clinically oriented, multidisciplinary annual Congress with a strong educational focus.
Reasons to attend:
Browse the Online Searchable Programme
View the Society Day Programmes
The programme is built around four key pillars:
Presenting the new practice changing phase III trials (in any tumour type) that will mature at the end of 2016. ECCO2017 will also put into a multidisciplinary perspective practice changing trials that were presented in monodisciplinary conferences in 2016.
Presenting and reviewing real world data to observe how recent implementation of new treatments or diagnostic modalities fared in the clinic. Emphasis will be placed on population registries, molecular epidemiology, elderly patients and co-morbidity as well as external validity of clinical trials.
Discussing the cost effectiveness of the molecular characterisation of cancer, new cancer therapies and how to prioritise and integrate these advances.
Discussing how the patient will be optimally guided in the future in through their diagnosis, treatment, supportive and palliative care, given the ageing population, oncology workforce shortage, increased number of survivors and the impact of ehealth (healthcare practice supported by electronic processes and communication such as electronic health records, telemedicine, clinical decision support etc).